Biontech founder Özlem Türeci expects the vaccine for five- to 11-year-olds to be available in just a few weeks. The results from the study with children will be presented to authorities worldwide in the coming weeks, Türeci said in an interview with Der Spiegel on Friday (Sept. 10). “Furthermore, we will apply for approval, including here in Europe.” The vaccine is the same as administered to adults, he said, but it has a lower dosage and must be filled differently. According to the Spiegel article, study data on children six months and older are also expected by the end of the year.
Meanwhile, a commission of the World Health Organization (WHO) has called on its member states to undertake comprehensive reforms of their healthcare systems. Despite repeated warnings of a global pandemic, the world was not prepared for the coronavirus, the WHO Regional Office for Europe said Friday (Sept. 10). The occasion is the publication of a final report by the commission headed by former Italian Prime Minister Mario Monti, which was set up during the pandemic. Contradictory and flawed policy steps had led to the consequences of Covid-19 being catastrophic and continuing to be so. More than 1.2 million people had died in association with Corona disease in the European region, he said, and the economy had also experienced an unprecedented downturn that dwarfed even the 2008 global financial crisis.
- source: nzz.ch/picture: pixabay.com
This post has already been read 297 times!